Crossject secures funding from French Government for needle-free platform
The cash injection will accelerate the development of Crossject’s prefilled needle-free platform to treat anaphylactic shock.
Drug Development
NVIDIA doubles down on AI in healthcare with drug discovery deals
FDA doubles down on patient engagement to support rare disease research
Innovation takes precedence with AI use for techbios in pharma
Anagenex and Nimbus team up for small molecule drug discovery
AbbVie partners with BigHat to develop antibody therapies
Amgen and MSD-backed start-up wins $10m for drug and device development
PostEra joins forces with Amgen for AI drug discovery
